Startseite The crystal structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
Artikel Open Access

The crystal structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

  • Hui-Zhen Wu , Li-Jing Min , Liang Han , Xing-Hai Liu und Na-Bo Sun ORCID logo EMAIL logo
Veröffentlicht/Copyright: 18. Juni 2021

Abstract

C12H9ClFN3, monoclinic, C2/c (no. 15), a = 24.713(13) Å, b = 15.459(13) Å, c = 17.507(12) Å, β = 17.515(11)°, V = 4742(6) Å3, Z = 16, R gt (F) = 0.0530, wR ref (F2) = 0.1161, T = 113(2) K.

CCDC no.: 2084102

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless plate
Size: 0.20 × 0.20 × 0.20 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.31 mm−1
Diffractometer, scan mode: Rigaku Saturn, ω
θmax, completeness: 27.9°, >99%
N(hkl)measured, N(hkl)unique, Rint: 23,772, 2832, 0.056
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 2622
N(param)refined: 154
Programs: XSCANS [1], Olex2 [2], Shelx [3], [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
Cl1 −0.92004 (3) −0.11885 (3) −0.60976 (3) 0.03474 (17)
F1 −0.57434 (7) 0.08219 (7) −0.61849 (7) 0.0368 (3)
N1 −0.87759 (8) −0.01892 (8) −0.38450 (9) 0.0225 (3)
N2 −0.80485 (8) −0.02867 (8) −0.51000 (9) 0.0222 (3)
H2 −0.7941 −0.0502 −0.5609 0.027*
N3 −0.74479 (8) 0.00490 (8) −0.46704 (10) 0.0207 (3)
C1 −0.94229 (11) −0.03331 (11) −0.34138 (12) 0.0274 (4)
H1 −0.9463 −0.0157 −0.2848 0.033*
C2 −1.00338 (11) −0.07264 (11) −0.37587 (12) 0.0297 (4)
H2A −1.0475 −0.0812 −0.3439 0.036*
C3 −0.99637 (10) −0.09895 (11) −0.46004 (13) 0.0278 (4)
H3 −1.0362 −0.1257 −0.4858 0.033*
C4 −0.93059 (10) −0.08534 (10) −0.50494 (12) 0.0223 (4)
C5 −0.87071 (9) −0.04435 (9) −0.46563 (11) 0.0192 (3)
C6 −0.68606 (10) 0.01864 (10) −0.51451 (11) 0.0217 (4)
H6 −0.6874 0.0068 −0.5731 0.026*
C7 −0.61711 (9) 0.05274 (9) −0.47727 (11) 0.0212 (4)
C8 −0.60253 (10) 0.05541 (10) −0.38852 (12) 0.0253 (4)
H8 −0.6381 0.0354 −0.3500 0.030*
C9 −0.53572 (11) 0.08746 (11) −0.35719(13) 0.0306 (4)
H9 −0.5268 0.0887 −0.2979 0.037*
C10 −0.48232 (11) 0.11750 (12) −0.41319 (14) 0.0359 (5)
H10 −0.4377 0.1390 −0.3916 0.043*
C11 −0.49508 (11) 0.11575 (12) −0.50152 (14) 0.0351 (5)
H11 −0.4595 0.1360 −0.5398 0.042*
C12 −0.56143 (10) 0.08347 (11) −0.53132 (12) 0.0263 (4)

Source of material

According to the literature methods [5], 3-chloro-2-hydrazinylpyridine and 2-fluorobenzaldehyde was added into the round bottom in EtOH. The mixture was stirred at room temperature overnight. Then the mixture was filtered and dried with 85% yield. The title compound was recrystallized from ethanol at room temperature to obtain colorless block crystals.

Experimental details

The structure was solved by direct methods with the SHELXS program. Hydrogen atoms were positioned geometrically (C–H = 0.93–0.98 Å). Their U iso values were set to 1.2 U eq or 1.5 U eq of the parent atoms.

Comment

Nowadays, nitrogen-linked heterocycles have received important attentions because of their divers bioactivities [6], [7], [8]. The pyridine derivatives often possess excellent biological activities, such as herbicidal activity [9], antifungal activity [10], anti-HIV [11], insecticidal [12] and so on. On the other hand, the hydrazone group is an active group in many bioactive molecules [13].

Generally, the average bond lengths and bond angles of ring systems (phenyl and pyridine) are normal. The C6=N2 bond [1.285(2) Å] is a little bit longer than the general C=N double bond length of 1.27 Å [14]. The torsion angle of N(2)–N(3)–C(6)–C(7) is −178.60(15)° similar to related structures [15]. More importantly, the target compound is in an E configuration. In the crystal structure, there are two intermolecular N–H···N hydrogen bonds that lead to a chain structure.


Corresponding author: Na-Bo Sun, College of Biology and Environmental Engineering, Zhejiang Shuren University, Hangzhou, 310015, China, E-mail:

Funding source: Natural Science Foundation of Zhejiang Province

Award Identifier / Grant number: LY19C140002

Award Identifier / Grant number: LY19B020009

Funding source: Chemical Company for Research

Award Identifier / Grant number: KYY-HX-20210140

Award Identifier / Grant number: KYY-HX-20190720

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Zhejiang Provincial Natural Science Foundation of China (Nos. LY19C140002, LY19B020009), the Chemical Company for Research (KYY-HX-20210140, KYY-HX-20190720).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku. CrystalClear; Rigaku Corporation: Tokyo, Japan, 2012.Suche in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8. https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122. https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed

5. Wang, Q., Shi, Y. X., Yang, M. Y., Sun, Z. H., Weng, J. Q., Tan, C. X., Liu, X. H., Li, B. J. Synthesis of some novel hydrazone derivatives as antifungal agents. J. Chem. Soc. Pakistan 2016, 38, 594–599.Suche in Google Scholar

6. Liu, X. H., Yu, W., Min, L. J., Wedge, D. E., Tan, C. X., Weng, J. Q., Wu, H. K., Cantrell, C. L., Bajsa–Hischel, J., Hua, X. W., Duke, S. O. Synthesis and pesticidal activities of new quinoxalines. J. Agric. Food Chem. 2020, 68, 7324–7332. https://doi.org/10.1021/acs.jafc.0c01042.Suche in Google Scholar PubMed

7. Fu, Q., Cai, P. P., Cheng, L., Zhong, L. K., Tan, C. X., Shen, Z. H., Han, L., Liu, X. H. Synthesis and herbicidal activity of novel pyrazole aromatic ketone analogs as HPPD inhibitor. Pest Manag. Sci. 2020, 76, 868–879. https://doi.org/10.1002/ps.5591.Suche in Google Scholar PubMed

8. Hua, X. W., Liu, W. R., Su, Y. Y., Liu, X. H., Liu, J. B., Liu, N. N., Wang, G. Q., Jiao, X. Q., Fan, X. Y., Xue, C. M., Liu, Y., Liu, M. Studies on the novel pyridine sulfide containing SDH based heterocyclic amide fungicide. Pest Manag. Sci. 2020, 76, 2368–2378. https://doi.org/10.1002/ps.5773.Suche in Google Scholar PubMed

9. Liu, X. H., Xu, X. Y., Tan, C. X., Weng, J. Q., Xin, J. H., Chen, J. Synthesis, crystal structure, herbicidal activities and 3D-QSAR study of some novel 1,2,4-triazolo[4,3-a]pyridine derivatives. Pest Manag. Sci. 2015, 71, 292–301. https://doi.org/10.1002/ps.3804.Suche in Google Scholar PubMed

10. Liu, X. H., Fang, Y. M., Xie, F., Zhang, R. R., Shen, Z. H., Tan, C. X., Weng, J. Q., Xu, T. M., Huang, H. Y. Synthesis and in vivo fungicidal activity of some new quinoline derivatives against rice blast. Pest Manag. Sci. 2017, 73, 1900–1907. https://doi.org/10.1002/ps.4556.Suche in Google Scholar PubMed

11. Kammari, K., Devaraya, K., Bommakanti, A., Kondapi, A. K. Development of pyridine dicoumarols as potent anti HIV-1 leads, targeting HIV-1 associated topoisomeraseII beta kinase. Future Med. Chem. 2017, 9, 1597–1609. https://doi.org/10.4155/fmc-2017-0091.Suche in Google Scholar PubMed

12. Dai, H., Chen, J., Hong, Y., Yuan, B. Y., Fan, C. G., Ma, R. Y., Liang, Z. P., Shi, J. Synthesis and bioactivities of novel pyrazole oxime ester derivatives containing pyridyl moiety. Chin. J. Org. Chem. 2017, 37, 1542–1547. https://doi.org/10.6023/cjoc201701042.Suche in Google Scholar

13. Shen, Z. H., Sun, Z. H., Becnel, J. J., Estep, A., Wedge, D. E., Tan, C. X., Weng, J. Q., Han, L., Liu, X. H. Synthesis and mosquiticidal activity of novel hydrazone containing pyrimidine derivatives against Aedes aegypti. Lett. Drug Des. Discov. 2018, 15, 951–956. https://doi.org/10.2174/1570180815666180102141640.Suche in Google Scholar

14. Chen, W. T., Wang, Q., Min, L. J., Wu, H. K., Weng, J. Q., Tan, C. X., Zhang, Y. G., Hu, B. Z., Liu, X. H. Synthesis, crystal structure, fungicidal activity, molecular docking, and density functional theory study of 2-chloro-N-(p-tolylcarbamoyl)nicotinamide. Indian J. Heterocycl. Chem. 2019, 29, 429–435.Suche in Google Scholar

15. Liu, W. Crystal structure of N′,2-bis((E)-2-chloro-6-hydroxybenzylidene)hydrazine-1-carbothiohydrazide, C15H12Cl2N4O2S. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 99–100. https://doi.org/10.1515/ncrs-2019-0518.Suche in Google Scholar

Received: 2021-04-29
Accepted: 2021-05-17
Published Online: 2021-06-18
Published in Print: 2021-09-27

© 2021 Hui-Zhen Wu et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of [aqua-(4-iodopyridine-2,6-dicarboxylato-κ3 O,N,O′)-(1,10-phenanothroline-κ2 N,N′)copper(II)] dihydrate, C19H16O7N3CuI
  4. The crystal structure of tetrakis(1-isopropyl-1H-imidazolium) octamolybdate, C24H44Mo8N8O26
  5. Crystal structure of catena-poly[bis(µ2-3,5-bis(1-imidazolyl)pyridine-κ2 N:N′)-(µ2-3-nitrophthalato-k3 O,O′:O″)cadmium(II)] dihydrate, C30H25N11O8Cd
  6. The crystal structure of diaqua-bis(2-(3-(1H-pyrazol-4-yl)-1H-1,2,4-triazol-5-yl)pyridine-κ2 N:N′)-bis(3,5-dicarboxybenzoato-κ1 O)cobalt(II), C38H30CoN12O14
  7. Crystal structure of the nickel(II) complex aqua-(2,6-di(pyrazin-2-yl)-4,4′-bipyridine-κ3 N,N′,N′′)-(phthalato-κ2 O,O′)nickel(II) tetrahydrate, C26H26N6O9Ni
  8. The crystal structure of 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]-N-methylmethanaminium 3-carboxyprop-2-enoate, C21H20FN3O6S
  9. The crystal structure of 1,2-bis(4-pyridyl)ethane - 4,4-dihydroxydiphenylmethane (1/1), C25H21N2O2
  10. Crystal structure of bis(2-((E)-5-chloro-2-hydroxybenzylidene)hydrazineyl)methaniminium trifluoroacetate dihydrate, C34H36Cl4N10O12
  11. Crystal structure of 1-cyclopropyl-7-ethoxy-6,8-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, C15H13F2NO4
  12. Crystal structure of methyl 3-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzoate, C18H15BN2O2
  13. Crystal structure of (E)-N′-(2-chloro-6-hydroxybenzylidene)-2-hydroxybenzohydrazide, C14H11ClN2O3
  14. Crystal structure of Al-rich fluorophlogopite, K1.0(Mg2.8Al0.2)(Si2.8Al1.2)O10F2
  15. The crystal structure of 4,5-diiodo-1,3-dimesityl-1H-1,2,3-triazol-3-ium hexafluoridoantimonate(V), C20H22F6I2N3Sb
  16. Crystal structure of tris(3-iodopyridin-1-ium) catena-poly[(hexachlorido-κ1 Cl)-(μ2-trichlorido-κ2 Cl:Cl)diantimony(III)], C15H15Cl9I3N3Sb2
  17. Crystal structure of methyl 2-(1H-naphtho[1,8-de][1.3.2]diazaborinin-2(3H-yl)benzoate C18H15BN2O2
  18. The crystal structure of 1,8-bis(4-methoxybenzoyl)naphthalene-2,7-diyl dibenzoate, C40H28O8
  19. Crystal structure of 2-bromo-1,3,6,8-tetramethylBOPHY (BOPHY = bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine), C14H15B2BrF4N4
  20. The crystal structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  21. Crystal structure of bis(µ2- 4-iodopyridine-2,6-dicarboxylato-κ3O:N:O′)-bis(4-iodopyridine-2,6-dicarboxylato-κ3O:N:O′)-bis(µ2-1-(4-pyridyl)piperazine-κ2N:N′)-hexa-aqua-tetra-copper(II), C46H46Cu4I4N10O22
  22. Crystal structure of poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ2O:O′)(μ2-bis(4-pyridylformyl)piperazine-κ2N:N′)cadmium(II)] dihydrate, C24H28CdN4O12
  23. Crystal structure of poly[aqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-(μ3-2,3,5,6-tetrafluoroterephthalato-κ3O:O′:O′′)cadmium(II)], C17H14N4O5F4Cd
  24. Crystal structure of 6-(quinolin-8-yl)benzo[a]phenanthridin-5(6H)-one, C26H16N2O
  25. The crystal structure of aqua-bis(6-chloropicolinato-κ2N,O)copper(II), C12H8Cl2N2O5Cu
  26. Crystal structure of catena-poly[diaqua-bis(μ2-4,4′-bipyridyl-κ2N:N′) disilver(I)] 4-oxidopyridine-3-sulfonate trihydrate, C25H29Ag2N5O9S
  27. The crystal structure of 4-(3-bromophenyl)pyrimidin-2-amine, C10H8BrN3
  28. Crystal structure of 6-oxo-4-phenyl-1-propyl-1,6-dihydropyridine-3-carbonitrile, C15H14N2O
  29. Crystal structure of 4-(2,2-difluoroethyl)-2,4-dimethyl-6-(trifluoromethyl)isoquinoline-1,3(2H,4H)-dione, C14H12F5NO2
  30. Crystal structure of dibromido-(1-methyl-1H-imidazole-κ1N)-(3-(3-methyl-1H-imidazol-3-ium-1-yl)propanoato-κ1O)zinc(II), C11H16Br2N4O2Zn
  31. The crystal structure of 1,1′-(((2 (dimethylamino)ethyl)azanediyl)bis(methylene)) bis(naphthalen-2-olato-κ4 N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)- titanium(IV) ─ dichloromethane (2/1), C33H29N3O6Ti
  32. The layered crystal structure of bis(theophyllinium) hexachloridostannate (IV), C14H18N8O8SnCl6
  33. The crystal structre of 3-(1-ethenyl-1H-imidazol-3-ium-3-yl)propane-1-sulfonate, C8H12N2O3S
  34. Synthesis and crystal structure of di-tert-butyl 1″-acetyl-2,2″,9′-trioxo-4a′,9a′-dihydro-1′H,3′H,9′H-dispiro[indoline-3,2′-xanthene-4′,3″-indoline]-1,3′-dicarboxylate, C39H38N2O9
  35. The crystal structure of 4-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  36. The crystal structure of 1-fluoro-4-(p-tolylethynyl)benzene, C15H11F
  37. The crystal structure of bis[4-bromo-2-(1H-pyrazol-3-yl) phenolato-κ2N,O] copper(II), C18H12Br2CuN4O2
  38. The crystal structure of poly[(μ 3-imidazolato-κ 3 N:N:N′)(tetrahydrofuran- κ 1 O)lithium(I)], C7H11LiN2O
  39. Crystal structure of N′,N′′′-((1E,1′E)-(propane-2,2-diylbis(1H-pyrrole-5,2diyl))bis(methaneylylidene))di(nicotinohydrazide) pentahydrate, C25H24N8O2·5H2O
  40. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-ethyl-1H-imidazol-3-ium hexafluoridophos-phate(V), C9H15F6N2O2P
  41. Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(3-thiophenecarboxylato-κ2O,O′)copper(II), C22H14N2O4S2Cu
  42. The crystal structure of 2-amino-3-carboxypyridin-1-ium iodide hemihydrate, C6H8IN2O2.5
  43. Crystal structure of (E)-7-methoxy-2-((6-methoxypyridin-2-yl)methylene)-tetralone, C18H17NO3
  44. The crystal structure of [μ-hydroxido-bis[(5,5′-dimethyl-2,2′-bipyridine-κ2N,N′)-tricarbonylrhenium(I)] bromide hemihydrate, C30H26N4O9Re2Br
  45. The crystal structure of 2,5-bis(3,5-dimethylphenyl)thiazolo[5,4-d]thiazole, C20H18N2S2
  46. The crystal structure of 5-benzoyl-1-[(E)-(4-fluorobenzylidene)amino]-4-phenylpyrimidin-2(1H)-one, C24H16FN3O2
  47. Crystal structure of monocarbonyl(N-nitroso-N-oxido-phenylamine-κ 2 O,O′)(tricyclohexylphosphine-κP)rhodium(I), C25H39N2O3PRh
  48. Crystal structure of poly[bis[μ3-1,3,5-tris[(1H-imidazol-1-yl)methyl]benzene-κ3N:N′:N″]nickel(II)] hexafluorosilicate, C36H36N12NiSiF6
  49. The crystal structure of 13-(pyrazole-1-yl-4-carbonitrile)-matrine, C19H25N5O
  50. Crystal structure of 3,5-bis((E)-4-methoxy-2-(trifluoromethyl)benzylidene)-1-methylpiperidin-4-one, C24H21F6NO3
  51. The crystal structure of N,N′-(Disulfanediyldi-2,1-phenylene)di(6′-methylpyridine)-2-carboxamide, C26H22N4O2S2
  52. Crystal structure of (E)-7-fluoro-2-(4-methoxy-2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  53. Crystal structure of ethyl 1-(4-fluorophenyl)-4-phenyl-1H-pyrrole-3-carboxylate, C19H16FNO2
  54. The crystal structure of cis-diaqua-bis (N-butyl-N-(pyridin-2-yl)pyridin-2-amine-κ2N,N′)cobalt(II)] dichloride trihydrate, C28H44Cl2N6O5Co
  55. Crystal structure of (E)-7-methoxy-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C18H17NO3
  56. Crystal structure of (E)-2-((3-fluoropyridin-4-yl)methylene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  57. The crystal structure of 6-bromohexanoic acid, C6H11BrO2
  58. The crystal structure of 4-chloro-thiophenol, C6H5ClS
  59. The crystal structure of 4-bromobenzyl chloride, C7H6BrCl
  60. The crystal structure of di-tert-butyl dicarbonate, C10H18O5
  61. The crystal structure of (2-(4-chlorophenyl)-5-methyl-1,3-dioxan-5-yl)methanol, C12H15ClO3
  62. The crystal structure of the co-crystal: 2-hydroxybenzoic acid – N′-(butan-2-ylidene)pyridine-4-carbohydrazide, C10H13N3O·C7H6O3
  63. Crystal structure and anti-inflammatory activity of (E)-7-fluoro-2-((5-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  64. Crystal structure of (E)-7-fluoro-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  65. Crystal structure of 1,1′-(butane-1,4-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C32H56F24N8P4
  66. The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2)-cadmium(II), C14H20CdCl2N4O4
  67. Crystal structure of 1-(2-cyanobenzyl)-3-cyano-4-phenyl-4-(2-cyanobenzyl)-1,4-dihydropyridine monohydrate, C56H42N8O
  68. The crystal structure of 3-(carboxymethyl)-1-ethenyl-1H-imidazol-3-ium chloride, C7H9N2O2Cl
  69. The crystal structure of adamantylmethoxydiphenylsilane, C23H28OSi
  70. Redetermination of the crystal structure of (2E,4Z,13E,15Z)-3,5,14,16-tetramethyl-2,6,13,17-tetraazatricyclo[16.4.0.07,12]docosa-1(22),2,4,7,9,11,13,15,18,20-decaene, C22H24N4
  71. Crystal structure of (E)-7-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H15NO3
  72. Crystal structure of catena-poly[diaqua-bis(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2 N:N′)cobalt(II)] dinitrate, C18H28N10O8Co
Heruntergeladen am 22.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0164/html
Button zum nach oben scrollen